Effects of Clopidogrel and Clarithromycin on the Disposition of Sibutramine and Its Active Metabolites M1 and M2 in Relation to CYP2B6*6 Polymorphism.

Trial Profile

Effects of Clopidogrel and Clarithromycin on the Disposition of Sibutramine and Its Active Metabolites M1 and M2 in Relation to CYP2B6*6 Polymorphism.

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Sep 2012

At a glance

  • Drugs Sibutramine (Primary) ; Clarithromycin; Clopidogrel
  • Indications Bacterial infections; Heart failure; Hyperlipidaemia; Ischaemic heart disorders; Obesity
  • Focus Pharmacokinetics
  • Most Recent Events

    • 25 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top